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SUMMARY 
We have isolated a cDNA clone corresponding to a substantial portion of the human tissue-type plasminogen 
activator (t-PA) protein. It encodes almost all of the protein B chain and part of the 3’ untranslated region. 
We have used this clone to screen bacteriophage I and cosmid libraries of human genomic DNA. Several 
related genomic clones were isolated. One of these, a cosmid clone, carried approx. 40 kb of human DNA. 
Mapping experiments indicate that the region containing the protein-coding exons is approx. 20 kb in length. 
The cosmid, containing the t-PA gene and the aminoglycosyl-3’-phosphotransferase dominant-selection 
marker, was introduced into mouse L cells. Approximately half of the transformants were shown to produce 
human t-PA. We demonstrated that the fibrinolytic t-PA activity could be specifically quenched by anti-t-PA 
antibody and that the recombinant -PA was of similar size (by SDS-polyacrylamide gel electrophoresis) to 
the t-PA produced by the human Bowes melanoma cell line. Our results suggest that the cosmid clone carries 
the whole t-PA coding region together with the regulatory elements necessary for its expression. 
INTRODUCTION 
Plasminogen activators appear to play an impor- 
tant role in the tibrinolytic system. These enzymes 
are capable of converting inactive plasminogen to its 
catalytically active form, plasmin, which degrades 
Abbreviations: bp, base pair(s); EtBr, ethidium bromide; HPLC, 
high-performance liquid chromatography; kb, 1000 bp; SDS, 
sodium dodecyl sulphate; SSC, 0.15 M NaCl, 0.015 M 
Na, . citrate, pH 7-8; t-PA, human tissue-type plasminogen acti- 
vator; u-PA, human urokinase-type plasminogen activator. 
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the fibrin network associated with blood clots. There 
are two major types of human plasminogen activator, 
namely urokinase-type plasminogen activator (U-PA) 
and tissue-type plasminogen activator (t-PA). These 
proteins are immunologically distinct, differ in M, 
and are encoded by different genes (Heyneker et al., 
1982; Pennica et al., 1983). Particular attention has 
been drawn to the clinical use of t-PA since recent 
studies indicate that administration of t-PA may 
provide therapeutic benefit in iliofemoral thrombosis 
(Weimar et al., 1981) and in thrombolysis of 
myocardial infarctions (Van de Werf et al., 1984). 
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The current method of production of t-PA from the 
human Bowes melanoma cell line is, however, 
unlikely to provide sufficient t-PA for future clinical 
needs (Rijken and Collen, 1981; Van de Werf et al., 
1984). As a consequence, a number of laboratories 
are attempting to produce t-PA by means of recom- 
binant DNA technology. Thus cDNA clones have 
been obtained (Pennica et al., 1983; Edlund et al., 
1983) and the t-PA cDNA expressed in E.scherichiu 
coli (Pennica et al., 1983). We decided to isolate the 
genomic DNA for t-PA in order to provide a basis 
for a better understanding of the t-PA molecule. We 
were also interested in the feasibility of expressing 
the t-PA gene in mammalian cell culture since t-PA 
synthesised in E. coli is not glycosylated (Pennica 
et al., 1983). We took advantage of recent advances 
in cosmid cloning technology which, combined with 
new dominant selection markers, facilitate the iso- 
lation of genomic DNA clones spanning even rela- 
tively large genes and the direct expression of such 
genes in eukaryotic systems (Grosveld et al., 1982). 
MATERIALS AND METHODS 
(c) Identification of a t-PA cDNA clone 
10 pg of total mRNA was used to prepare a 
cDNA library of approx. 50000 recombinants. The 
cDNA was inserted into the pCD5 plasmid vector by 
dC : dG tailing and transformed into E. coli DH 1 
cells as described by Scott et al. (1983). The library 
was propagated on nitrocellulose filters and replicas 
were prepared for screening (Ham&an and Mesel- 
son, 1980). Hybridising colonies were detected by 
autoradiography. 
(d) Oligonucleotide probes 
Oligonucleotide probes were synthesised from 
dimer building blocks by the solid phase phospho- 
triester method (Gait et al., 1982) and purified by 
preparative ion-exchange HPLC. Probes were end- 
labelled to a specific activity of 5 x 10’ dpm/pg with 
[ Y-~‘P] ATP as described by Maxam and Gilbert 
(1980). Hybridisations were performed, at 37 o C for 
16 h, essentially as described by Dalbadie-Mac- 
Farland et al. (1982), except that 0.1% SDS was 
substituted for NP40 in the hybridisation buffer. 
Filters were then washed for 4 x 15 min in 6 x SSC 
containing 0.1% SDS at 45°C. 
(a) Enzymes and special materials 
(e) Identification of genomic t-PA clones 
Restriction endonucleases, T4 DNA ligase and 
polynucleotide kinase were obtained from Bethesda 
Laboratories (U.K.) Ltd. Nitrocellulose filters (BA 
85) were from Schleicher & Schttll GmbH, Dassel, 
W. Germany, and GeneScreenTM was from New 
England Nuclear, Boston, MA, U.S.A. Urokinase 
was from Leo Laboratories Ltd., U.K. Human 
fibrinogen was from Flow Laboratories, Irvine, U.K. 
Radioisotopically labelled compounds and nick- 
translation kits were from Amersham International 
plc, U.K. Fuji-RX film was from Fujimex Ltd., 
Dorcan, U.K. Antibiotic G418 sulphate was from 
Gibco Europe Ltd., Paisley, U.K. 
(b) Purification of messenger RNA 
Total RNA was isolated from Bowes melanoma 
cells (Rijken and Cohen, 1981) by phenol extraction 
(Scott et al., 1983) and mRNA was purified by single 
cycles of poly(U)-Sepharose or oligo(dT)-cellulose 
chromatography (Legon et al., 1982). 
An amplified 2 Charon 4A bacteriophage human 
DNA library, kindly provided by T. Maniatis (Lawn 
et al., 1978), was propagated in E. coli LE392, and 
nitrocellulose copies were prepared for screening 
(Benton and Davis, 1977). A further human DNA 
library of 5 x lo5 independent recombinants was 
prepared in the pTCF cosmid vector and nitro- 
cellulose replicas were prepared for screening as 
described previously (Grosveld et al., 1982). Ge- 
nomic libraries were screened using the appropriate 
nick-translated probe as follows. Nitrocellulose til- 
ters were prehybridised in a solution of 3 x SSC, 
0.1 y0 SDS, 50 pg denatured sonicated salmon 
sperm DNA, 0.2% Ficoll, 0.2% bovine serum albu- 
min, 0.2% polyvinylpyrrolidone for 2 h at 65°C. 
Hybridisation was for 16 h at 65 “C in the same 
solution. Filters were washed for 6 x 30 min at 65’ C 
in 0.1 x SSC containing 0.1% SDS, followed by 
2 x 30-min washes at room temperature in 3 mM 
Tris base. 
(f) Northern and Southern blotting of nucleic acids 
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RESULTS ANDDISCUSSION 
mRNA was fractionated by electrophoresis in a 
1% agarose gel containing formaldehyde and then 
transferred to GeneScreen (Thomas, 1980). Human 
18 and 28 S ribosomal RNAs, stained with EtBr, 
were used as size markers. DNA was fractionated 
on agarose gels and blotted onto nitrocellulose as 
described by Southern (1975). 
(g) DNA sequencing 
The sequences of the oligonucleotide probes were 
verified by the method of Maxam and Gilbert (1980). 
Sequencing of cloned DNA was performed using the 
chain-termination method (Smith, 1980; Messing 
et al., 1981). 
(h) Transformation of mouse L cells 
Transformation of mouse L cells using cosmid 
DNA was carried out essentially as described pre- 
viously (Grosveld et al., 1982). 10 pg of cosmid 
DNA (without carrier) was precipitated onto approx. 
lo6 cells per 90-mm dish. Transformants were 
selected using 400 pg/ml G4 18 sulphate. Colonies of 
1 to 2 mm diameter were clearly visible 12 to 14 days 
after transformation and were individually harvested 
for propagation and assay of t-PA production. 
(i) Characterisation of t-PA 
Cell cultures were washed twice with serum-free 
medium and were incubated in serum-free medium 
for 48 h to harvest secreted t-PA. The medium was 
collected, Tween-80 added to 0.01% (w/v) and 
activity measured on fibrin plates (Granelli-Pipemo 
and Reich, 1978). The J4,. of plasminogen activators 
was determined by electrophoresis on 8% SDS- 
polyacrylamide gels using a 4% stacking gel 
(Laemmli, 1970) and the librinolytically active 
species identified by fibrin zymography (Granelli- 
Piperno and Reich, 1978). Where appropriate t-PA 
was purified by continuous chromatography using 
zinc chelate (Rijken and Collen, 1981) and lysine 
Sepharose. 
Antibodies to t-PA (from Bowes melanoma cells) 
or u-PA were raised in rabbits and the IgG fraction 
purified according to Hjelm et al. (1972). 
(a) Identification and isolation of a t-PA cDNA 
clone 
We constructed a nonadecameric oligonucleotide 
(probe 1) of sequence 5’-d(CCTGGTCACGGTC- 
GCATGT)-3’ which we reasoned would provide a 
unique probe for t-PA mRNA and its corresponding 
cDNA. This oligonucleotide sequence spans the 
boundary between the t-PA B chain coding region 
and the 3’ untranslated region of the mRNA (Pen- 
nica et al., 1983). The selectivity of the oligonucle- 
otide was assessed by probing a Northern blot of 
Bowes melanoma cell mRNA. Under appropriate 
conditions we observed a single hybridising band 
which migrated between the 18 S and 28 S ribosomal 
RNA markers. This result is consistent with previous 
estimates for the size of the t-PA mRNA (Pennica 
et al., 1983; Edlund et al., 1983). A cDNA library of 
approx. 50000 recombinants was prepared from 
Bowes melanoma cell mRNA and was probed under 
the same conditions as the Northern blot. A single 
clone (pTR5) was isolated and sequence analysis 
confirmed that it encoded part of the t-PA protein. 
The clone extends from nucleotide 1084 to nucle- 
otide 2109 of the full cDNA molecule (Pennica et al., 
1983) and corresponds to the majority of the t-PA B 
chain (lacking only 69 bp at the 5’ end) plus a large 
segment of the 3’ untranslated region. 
(b) Identification and isolation of t-PA genomic 
DNA clones 
The plasmid pTR5 was digested with &I and 
Sal1 to release the t-PA cDNA (Legon et al., 1982) 
which was then separated from vector DNA by 
agarose gel electrophoresis (Maniatis et al., 1982) 
and nick-translated to a specific activity of 1 to 
3 x lo8 dpm/pg (Rigby et al., 1977). 
1.3 x lo6 recombinants from the bacteriophage 
library were screened with the t-PA cDNA probe as 
describedin MATERIALS AND METHODS, sectione, 
and seven recombinants were isolated. Restriction 
enzyme analysis of these cloned genes revealed that 
they were all very similar (not shown). 
8 x lo5 colonies from the cosmid library, which 
originally contained 5 x lo5 colonies, were also 
screened with the t-PA cDNA probe and two colo- 
nies were isolated. Restriction enzyme analysis 
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showed both of the cosmids to be identical (pre- 
sumably originating from the same initial recombi- 
nant) and that they carried approximately 40 kb of 
human DNA. 
(c) Characterisation of t-PA genomic DNA 
The bacteriophage and cosmid clones were com- 
pared to the uncloned t-PA gene (in a total placental 
DNA preparation) by restriction enzyme analysis 
and Southern blotting using the nick-translated t-PA 
cDNA probe. BgZII digestion revealed the presence 
of a common single hybridising fragment of approx. 
5.8 kb in length. Thus most, if not ah, of the t-PA B 
chain is coded on this BgZII fragment. We have 
mapped the cosmid with BumHI, ClaI, KpnI, PvuI 
and Sal1 (Fig. 1) and located the 5.8-kb BglII frag- 
ment. Further mapping experiments (not shown) 
enabled us to assign the orientation of the Bg/II 
fragment with respect to the cDNA clone and (using 
probe 1) to locate the 3’ end of the coding region 
(Fig. 1). 
It was also of interest to determine whether any 
of the clones encoded the whole amino acid sequence 
of the t-PA protein. A second probe, with the 
sequence 5 ’ -d(CCCTCTCTTCATTGCATCC)-3 ’ , 
corresponding to the N-terminal region of the t-PA 
hydrophobic signal peptide (Pennica et al, 1983) 
was used to examine the genomic clones. None of the 
bacteriophage I clones hybridised to probe 2 indicat- 
ing that they probably lacked the 5’ end of the gene. 
Probe 2 hybridised to a 3.9-kb BamHI-KpnI frag- 
ment on the cosmid clone (Fig. 1). The fidelity of 
5’ 
hybridisation was confirmed by subcloning and 
sequencing part of the 3.9-kb BarnHI-KpnI fragment 
(not shown). Location of probe 2 on this fragment 
indicates that the region containing the amino acid 
coding exons is between 17 and 21 kb long. 
(d) Expression of the t-PA cosmid clone 
The isolation of human t-PA bacteriophage (Pen- 
nica et al., 1983) and cosmid (Ny et al., 1984) 
genomic clones has been described previously. In 
neither case was it demonstrated whether the whole 
t-PA genetic locus had been cloned. While it is 
possible to define the protein-coding areas of a gene 
by mapping and DNA sequencing, there are no 
definitive means of detecting regulatory elements 
(such as promoters) solely by structural analysis of 
cloned DNA. To demonstrate that the whole gene 
was present on our cosmid we examined its ability to 
direct the synthesis of human t-PA, using the domi- 
nant aminoglycosyl-3’-phosphotransferase selection 
marker present in the pTCF vector (Grosveld et al., 
1982). 
Mouse L cells were chosen as the host for the t-PA 
cosmid since we had found that these cells do not 
normally secrete plasminogen activator(s). Addi- 
tionally, in the unlikely situation that manipulation of 
the L cells might induce the expression of an endo- 
genous murine plasminogen activator, we would be 
able to distinguish this from human t-PA on the basis 
of A4,. Thus it is known that there are two major 
types of human plasminogen activator: u-PA (M, 
53 000) and t-PA (M, 63 000-65000) (Heyneker 
3’ 
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Fig. 1. Map of the t-PA cosmid clone. All &I, KpnI, PvuI and Sal1 sites are shown; only relevant BamHI and BglII sites are shown. 
Black box represents the sole Bg/II (5.8-kb) fragment hybridising to the t-PA cDNA probe; hatched box represents the BumHI-KpnI 
fragment hybridising to probe 2 (corresponding to the N-terminus of hydrophobic signal peptide); the arrow indicates the BglII-KpnI 
fragment hybridising to probe 1 (3’ end ofprotein-coding region); open box represents pTCF vector. The total length of inserted human 
DNA is 40 kb. Bg = BglII; Bm = BarnHI; C = ClaI; K = KpnI; P = PvuI; S = SalI. 
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et al., 1982; Pennica et al., 1983). There is also a 
minor human t-PA component of approx. M, 56 000 
which is believed to be the product of limited 
proteolysis of the major species (Banyai et al., 1983). 
There are two analogous murine activators, one (M, 
48 000) immunologically related to u-PA and one (M, 
79000) immunologically related to t-PA (Marotti 
et al., 1982). 
Cosmid DNA was introduced into L cells as 
described in MATERIALS AND METHODS, section h. 
27 L-cell clones were isolated and assayed for t-PA 
production: 55% of the clones secreted t-PA. The 
quantity produced by individual clones varied con- 
siderably; the highest yielding clone, TRL25, pro- 
Mr xx)- 
90 
63 
56 
40 
33 
,3 
Fig. 2. SDS-polyacrylamide gel electrophoresis of t-PA. 20 ~1 
aliquots of Bowes melanoma cell-derived t-PA (lane 1) or recom- 
binant mouse L cell (TRL25)derived t-PA (lane 2) were electro- 
phoresed in SDS-containing gels until the marker dye reached 
the bottom of the gel. Plasminogen activator activity, visualised 
as clear lysis areas against the Amido Black-stained background, 
was detected by fibrin zymography as described in MATERIALS 
AND METHODS, section i. The Mr’s of the plasminogen acti- 
vators were determined by comparing their mobility to known 
standards. 
duced approx. 70 ng/ml t-PA. Analysis of the puri- 
fied protein by SDS-polyacrylamide gel electro- 
phoresis and fibrin zymography showed that the 
fibrinolytically active species were of similar size to 
those produced by the human Bowes melanoma cell 
line (Fig. 2). 
The identity of the recombinant protein was fur- 
ther confirmed as its fibrinolytic activity could be 
specifically quenched with anti-t-PA antibody where- 
as anti-u-PA antibody was without effect (not 
shown). Human t-PA and u-PA may also be distin- 
guished on the basis of their dose-response curves 
in the fibrin plate assay (Rijken et al., 1979); we 
observed that the recombinant t-PA dose-response 
curve was similar to that of Bowes melanoma cell 
t-PA (not shown). 
Expression of the human t-PA protein in mouse L 
cells suggests that our cosmid encodes all of the t-PA 
protein molecule and in addition carries all the rele- 
vant structures (such as the promoter and poly(A) 
addition site) necessary for expression. The cosmid 
clone is thus likely to encompass the whole of the 
t-PA genetic locus. 
The present study has also demonstrated the 
feasibility of expression of a cloned human t-PA gene 
in mammalian cell culture. While the yield of t-PA, 
even from our highest producing clone, is not at 
present optimal, there are now many methods of 
manipulating enes to increase expression (Rigby, 
1982). 
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